Knowledge and attitudes about influenza vaccination in rheumatic diseases patients

References

• Meroni PL, Zavaglia D, Girmenia C. Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol. 2018;36:317–28.
   PubMed Web of Science ®Google Scholar
• Blumentals WA, Arreglado A, Napalkov P, Toovey S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet Disord. 2012;13:158. doi:10.1186/1471-2474-13-158.
   PubMed Web of Science ®Google Scholar
• Sepriano A, Kerschbaumer A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JW, Burmester GR, de Wit M, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2020. doi:10.1136/annrheumdis-2019-216653.
   Google Scholar
• Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D’Amelio R, Dougados M, Kapetanovic MC, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open [Internet]; 2019 [accessed 2020 Apr 3]; 5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803008/.
   Google Scholar
• Somes MP, Turner RM, Dwyer LJ, Newall AT. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis. Vaccine. 2018;36:3199–207. doi:10.1016/j.vaccine.2018.04.063.
   PubMed Web of Science ®Google Scholar
• Bello SL, Serafino L, Bonali C, Terlizzi N, Fanizza C, Anecchino C, Lapaldula G. Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents. Reumatismo. 2012;64:299–306. doi:10.4081/reumatismo.2012.299.
   PubMedGoogle Scholar
• Mohammad AJ, Segelmark M, Smith R, Englund M, Nilsson J-Å, Westman K, Merkel PA, Jayne DRW. Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol. 2017;44:1468–75. doi:10.3899/jrheum.160909.
   PubMed Web of Science ®Google Scholar
• Ozawa S, Stack ML. Public trust and vaccine acceptance-international perspectives. Hum Vaccin Immunother. 2013;9:1774–78. doi:10.4161/hv.24961.
   PubMed Web of Science ®Google Scholar
• Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, Assen S, van Bijl M, Breedveld FC, D’Amelio R, Dougados M, Kapetanovic MC, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79:39–52. doi:10.1136/annrheumdis-2019-215882.
   PubMed Web of Science ®Google Scholar
• Ten health issues WHO will tackle this year [Internet]. [accessed 2020 Apr 3]. https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019.
   Google Scholar
• MacDonald NE. SAGE working group on vaccine hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Bridges MJ, Coady D, Kelly CA, Hamilton J, Heycock C. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:685. doi:10.1136/ard.62.7.685.
   PubMed Web of Science ®Google Scholar
• Haroon M, Adeeb F, Eltahir A, Harney S. The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics. Joint Bone Spine. 2011;78:374–77. doi:10.1016/j.jbspin.2010.10.012.
   PubMed Web of Science ®Google Scholar
• Hua C, Morel J, Ardouin E, Ricard E, Foret J, Mathieu S, Combe B, Lukas C. Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients. Rheumatology. 2015;54:748–50. doi:10.1093/rheumatology/keu531.
   PubMed Web of Science ®Google Scholar
• Harrison N, Poeppl W, Miksch M, Machold K, Kiener H, Aletaha D, Smolen JS, Forstner C, Burgmann H, Lagler H. Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases. Vaccine. 2018;36:4875–79. doi:10.1016/j.vaccine.2018.06.065.
   PubMed Web of Science ®Google Scholar
• Alqahtani AS, Althobaity HM, Al Aboud D, Abdel-Moneim AS. Knowledge and attitudes of Saudi populations regarding seasonal influenza vaccination. J Infect Public Health. 2017;10:897–900. doi:10.1016/j.jiph.2017.03.011.
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68:1–26.
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309–18. doi:10.1093/cid/cit816.
   PubMed Web of Science ®Google Scholar
• Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Christidis D, Galloway S, Hayes E, et al. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. Rheumatology. 2017;56:2257. doi:10.1093/rheumatology/kex389.
   PubMed Web of Science ®Google Scholar
• Cardiel MH, Carrillo S, Pérez M, et al. Update of the Mexican College of Rheumatology Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis, 2018 [published online ahead of print, 2019 May 15]. Actualización de las guías del tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología 2018 [published online ahead of print, 2019 May 15]. Reumatol Clin. 2019;S1699-258X(19)30079-8. doi:10.1016/j.reuma.2019.04.002
   Google Scholar
• Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, et al. Vaccination guidelines for patients with immune-mediated disorders taking immunosuppressive therapies: executive summary. J Rheumatol. 2019;46:751–54. doi:10.3899/jrheum.180784.
   PubMed Web of Science ®Google Scholar
• Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O’Dell J, Winthrop KL, Beukelman T, et al. Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64:625–39. doi:10.1002/acr.21641.
   PubMed Web of Science ®Google Scholar
• Fahy WA, Farnworth E, Yeldrem KP, Melling GS, Grennan DM. Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology. 2006;45:912–13. doi:10.1093/rheumatology/kel104.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O. Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis. 2008;67:1047. doi:10.1136/ard.2007.081703.
   PubMed Web of Science ®Google Scholar
• Feuchtenberger M, Kleinert S, Schwab S, Roll P, Scharbatke EC, Ostermeier E, Voll RE, Schäfer A, Tony H-P. Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int. 2012;32:1533–39. doi:10.1007/s00296-011-1808-z.
   PubMedGoogle Scholar
• Hmamouchi I, Winthrop K, Launay O, Dougados M. Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine. 2015;33:1446–52. doi:10.1016/j.vaccine.2015.01.065.
   PubMed Web of Science ®Google Scholar
• Brocq O, Acquacalda E, Berthier F, Albert C, Bolla G, Millasseau E, Destombe C, Azulay J, Asquier C, Florent A, et al. Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: a retrospective study. Joint Bone Spine. 2016;83:155–59. doi:10.1016/j.jbspin.2015.11.005.
   PubMed Web of Science ®Google Scholar
• Carrizales-Luna JP, Galarza-Delgado D, Esquivel-Valerio J, Serna-Peña G, Ramírez-Monterrubio L, Lozano-Plata L, Hernández-Galarza I, Gracia-Arechiga T. AB1248 vaccination rate in patients with rheumatic diseases: a cross-sectional study in mexican patients. Ann Rheum Dis. 2018;77:1720–1720. doi:10.1136/annrheumdis-2018-213920.
   PubMed Web of Science ®Google Scholar
• Murray K, O’Rourke A, Low C, Young F, Feeney E, Veale DJ. AB1250 vaccination awareness and uptake in inflammatory arthritis patients. Ann Rheum Dis. 2018;77:1721–1721.
   Web of Science ®Google Scholar
• Jiang Y, Zhang X, Lv Q, Qi J, Guo X, Wei Q, Liao Z, Lin Z, Gu J. Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China. Hum Vaccin Immunother. 2019;15:1100–05. doi:10.1080/21645515.2019.1568160.
   PubMed Web of Science ®Google Scholar
• Lejri-El Euchi H, Chirpaz E, Foucher A, Sultan-Bichat N, Randrianjohany A, Poubeau P, Gamon E, Roussin C, Osdoit S, Raffray L. Vaccination against influenza and pneumococcal infections in patients with autoimmune disorders under biological therapy: coverage and attitudes in patients and physicians. Eur J Intern Med. 2019;69:25–31. doi:10.1016/j.ejim.2019.08.010.
   PubMed Web of Science ®Google Scholar